Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Type (Droplet Digital PCR, Chip Based Digital PCR, Others), By Component (Systems, Kits and Assays, Reagents and Consumables), By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others), By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others), By Region and Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

Global Digital PCR Market is anticipated to witness a growth of steady CAGR in the forecast period 2024-2028. This can be ascribed to increasing prevalence of various type of cancer like blood cancer, lung cancer, brain tumour and surge in demand for healthcare expenditure of people in developing countries. Besides, growing demand for early and accurate diagnosis of various diseases across the globe has significantly increased the demand for molecular diagnostics, thereby supporting the growth of global digital PCR market. Additionally, advancement in digital PCR technology and increasing number of product launches increased the demand for digital PCR market for the forecast period. The demand in research and development activities for developing advancement in PCR technology and rising collaboration agreements between companies for development of digital PCR, boost the global digital PCR market for the forecast period. According to World Health Organization (WHO), in December 2021, 273 million cases are diagnosed and approximately 5.3 million deaths have been reported, globally, due to COVID-19.

Recent advancements in dPCR technology have led to increased sensitivity and accuracy, enabling the detection of rare genetic variants and low-level pathogens. This has important implications for cancer diagnosis and monitoring, infectious disease detection, and other areas of research. Integration of dPCR with next-generation sequencing (NGS) technologies is being explored to enhance the accuracy and sensitivity of genomic analysis. This combined approach can enable the detection of rare variants and copy number variations with high precision. Liquid biopsy is a non-invasive method of detecting and monitoring cancer by analyzing tumor DNA that is released into the bloodstream. dPCR is increasingly being used in liquid biopsy to detect and quantify circulating tumor DNA (ctDNA), providing a less invasive alternative to traditional biopsy methods. Developments in microfluidics and miniaturization are enabling the development of portable and cost-effective dPCR devices for point-of-care testing. This has important implications for disease detection and monitoring in low-resource settings.

Growing demand for precision medicine

Digital PCR enables the detection and quantification of rare genetic mutations with high accuracy, which is important for the development of precision medicine. The increasing demand for personalized medicine is expected to drive the demand for digital PCR. In the context of disease control, precision medicine can be particularly useful because it allows for the identification of specific disease-causing factors that may be unique to an individual. This can help to identify the best treatment approach for that individual, based on their specific genetic makeup and other personal characteristics. By tailoring treatment to the individual, precision medicine can increase the likelihood of successful treatment outcomes and reduce the risk of adverse side effects. Precision medicine is no longer limited to genetics alone. Researchers are increasingly exploring the use of other types of biomarkers, such as proteomics, metabolomics, and microbiomes, to better understand disease mechanisms and develop more targeted treatment approaches. There is a growing recognition of the importance of health equity in precision medicine. Efforts are underway to ensure that all individuals, regardless of their background or socioeconomic status, have access to the benefits of precision medicine. There is a growing interest in the role of nutrition in precision medicine. Researchers are exploring how individual variability in genetics, microbiome, and metabolism can affect nutrient requirements and the effectiveness of dietary interventions. This is leading to the development of personalized nutrition approaches that can be tailored to an individual's unique characteristics.

Rising Adoption of Digital PCR Devices

Despite the rising incidence of infectious diseases, cancer and genetic disorders across the globe and increasing prevalence of these conditions in emerging countries, the adoption of digital PCR techniques is limited in urban regions. However, initiatives taken by leading players to enhance the awareness about the digital PCR availability, increasing investments and initiatives by government organizations for the diagnosis of different chronic diseases, and establishment of strong distribution network will boost the overall market growth in the forecast period. Additionally, advancement in Digital PCR technology along with droplet, chip-based PCR, among others is expected to create new prospects for market growth in the coming years. Besides, increasing adoption of Digital PCR in laboratories for the detection of genetic mutation, detection of pathogens, among others is expected to support the market growth in the coming years. Furthermore, growing product applications in food microbiology and veterinary medicine will propel the digital PCR market in forecast period. Moreover, the sudden outbreak and spread of pandemic COVID-19 and widespread use of different types of PCR devices in COVID-19 testing has created new prospects for the growth of different types of PCR markets, including digital PCR market. In 2022, a total of 96,091,120 COVID-19 Cases are counted in the United States.

Growing adoption of non-invasive prenatal testing

Non-invasive prenatal testing (NIPT) is becoming increasingly popular, as it enables the detection of fetal genetic abnormalities without the need for invasive procedures. Digital PCR is a key technology used in NIPT, and the growing adoption of NIPT is expected to drive the demand for digital PCR. NIPT is an important development in prenatal testing for several reasons such as NIPT has been shown to have a high negative predictive value, meaning that if the test is negative, it is highly unlikely that the fetus has the genetic abnormality being tested for. This can reduce the need for invasive procedures such as amniocentesis or CVS, which are associated with a higher risk of complications. NIPT has been shown to be more accurate than traditional prenatal screening methods, such as maternal serum screening. This is because NIPT analyzes the fetal DNA directly, whereas maternal serum screening relies on measuring certain proteins and hormones in the mother's blood that are produced by the fetus.

Rising Fund for Research and Development Activities in the Digital PCR

Due to COVID19 pandemic, an unexpected demand was increased for Digital PCR in the healthcare and research institute sector. The pandemic has played an important role to enhance the digital PCR market growth. Prevalence of infectious diseases like cancer has also increasedwhich accounts for the need for the diagnosis and detection of the disease. For this reason, funding in the research and development sector has also increased. Increased funding for R&D activities that include the use of digital PCR and Chip based PCR for different purposes, is expected to increase its use and open up new opportunities for global market expansion during the forecast period. Governments and private organizations are investing heavily in genomics research, which is driving the demand for digital PCR technology. This investment is expected to continue to increase in the coming years, which will further boost the market growth. Genomics research has the potential to transform healthcare by enabling more personalized and targeted treatments. This can improve patient outcomes, reduce healthcare costs, and improve population health. Advances in genomics technologies have led to an explosion in the amount of data that can be generated and analyzed. This has opened up new opportunities for understanding the genetic basis of disease, developing new treatments, and improving public health. Genomics research can lead to the development of new products and services, such as gene therapies, diagnostics, and personalized medicine. This can create new industries and jobs, and contribute to economic growth. Genomics research can help to address public health concerns, such as emerging infectious diseases, antimicrobial resistance, and cancer. By understanding the genetic basis of these diseases, researchers can develop new strategies for prevention, diagnosis, and treatment. Many governments see genomics research as a strategic priority that can enhance their competitiveness in the global economy. By investing in genomics research, governments can attract talent, foster innovation, and build a knowledge-based economy.

Recent Development

Launched in 2021 by QIAGEN, this digital PCR system is designed for ultra-sensitive and accurate detection and quantification of target DNA and RNA sequences. It has a high dynamic range and can detect as few as two copies of a target sequence.
Launched in 2020 by JN Medsys, this digital PCR system is designed for the detection of SARS-CoV-2 virus in clinical samples. It uses a multiplex digital PCR assay to simultaneously detect two viral genes with high sensitivity and specificity.
Launched in 2019 by RainDance Technologies, this digital PCR system is designed for ultra-sensitive detection and quantification of nucleic acid targets. It uses microfluidic droplet technology to partition each sample into millions of droplets, each of which undergoes digital PCR amplification to detect and quantify target molecules.

Download Free Sample Report

Market Segmentation

Global Digital PCR market is segmented into by type, by component, by application, by end user, and by region. Based on type, the market can be segmented into Droplet Digital PCR, Chip Based Digital PCR, Others. Based on component, the market can be segmented into Systems, Kits and Assays, Reagents and Consumables. Based on application, the market can be differentiated into Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others. Based on end user, the market can be segmented into Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others. Regionally, North Americadominated the market among Asia Pacific, Europe, Middle East & Africa and South America. In terms of country, the United States region is dominating the overall globe in digital PCR market. According to Worldometer, as of December 26, 2022 around 102,236,095 confirmed COVID-19 cases have been reported in the United States. This can be ascribed to the increasing cost-effective COVID-19 testing technology in the healthcare sector.

Market Players

Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC are some of the leading players operating in the Global Digital PCR Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	By Type By Component By Application By End User By Region
Regional scope	North America; Europe; Asia Pacific; South America; Middle East & Africa
Country scope	United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; South Korea; Japan; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey
Key companies profiled	Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Digital PCR market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Digital PCR Market, By Type:

Droplet Digital PCR
Chip Based Digital PCR
Others

Digital PCR Market, By Component:

o Systems

o Kits and Assays

o Reagents

o Consumables

· Digital PCR Market, By Application:

o Oncology

o Infectious Diseases

o Rare Diseases

o Reproductive Genetics

o Others

· Digital PCR Market, By End User:

o Academic and Research Institutions

o Biotechnology & Pharmaceutical Companies

o Hospitals and Clinics

o Others

· Digital PCR Market, By Region:

North America

United States
Mexico
Canada

Europe

France
Germany
United Kingdom
Italy
Spain

Asia Pacific

China
India
South Korea
Japan
Australia

South America

Brazil
Argentina
Colombia

Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

§ Egypt

§ Turkey

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies present in Global Digital PCR Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Digital PCR Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital PCR Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)

5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)

5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)

5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)

5.2.5. By Region

5.2.6. By Company (2022)

5.3. Market Map

5.3.1. By Type

5.3.2. By Component

5.3.3. By Application

5.3.4. By End User

5.3.5. By Region

6. North America Digital PCR Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

6.2.2. By Component

6.2.3. By Application

6.2.4. By End User

6.2.5. By Country

6.3. North America: Country Analysis

6.3.1. United States Digital PCR Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Type

6.3.1.2.2. By Component

6.3.1.2.3. By Application

6.3.1.2.4. By End User

6.3.2. Mexico Digital PCR Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Type

6.3.2.2.2. By Component

6.3.2.2.3. By Application

6.3.2.2.4. By End User

6.3.3. Canada Digital PCR Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Type

6.3.3.2.2. By Component

6.3.3.2.3. By Application

6.3.3.2.4. By End User

7. Europe Digital PCR Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

7.2.2. By Component

7.2.3. By Application

7.2.4. By End User

7.2.5. By Country

7.3. Europe: Country Analysis

7.3.1. France Digital PCR Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Component

7.3.1.2.3. By Application

7.3.1.2.4. By End User

7.3.2. Germany Digital PCR Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. By Component

7.3.2.2.3. By Application

7.3.2.2.4. By End User

7.3.3. United Kingdom Digital PCR Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. By Component

7.3.3.2.3. By Application

7.3.3.2.4. By End User

7.3.4. Italy Digital PCR Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type

7.3.4.2.2. By Component

7.3.4.2.3. By Application

7.3.4.2.4. By End User

7.3.5. Spain Digital PCR Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type

7.3.5.2.2. By Component

7.3.5.2.3. By Application

7.3.5.2.4. By End User

8. Asia-Pacific Digital PCR Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Component

8.2.3. By Application

8.2.4. By End User

8.2.5. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Digital PCR Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Component

8.3.1.2.3. By Application

8.3.1.2.4. By End User

8.3.2. India Digital PCR Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Component

8.3.2.2.3. By Application

8.3.2.2.4. By End User

8.3.3. South Korea Digital PCR Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Component

8.3.3.2.3. By Application

8.3.3.2.4. By End User

8.3.4. Japan Digital PCR Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. By Component

8.3.4.2.3. By Application

8.3.4.2.4. By End User

8.3.5. Australia Digital PCR Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. By Component

8.3.5.2.3. By Application

8.3.5.2.4. By End User

9. South America Digital PCR Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Component

9.2.3. By Application

9.2.4. By End User

9.2.5. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Digital PCR Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Component

9.3.1.2.3. By Application

9.3.1.2.4. By End User

9.3.2. Argentina Digital PCR Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Component

9.3.2.2.3. By Application

9.3.2.2.4. By End User

9.3.3. Colombia Digital PCR Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Component

9.3.3.2.3. By Application

9.3.3.2.4. By End User

10. Middle East and Africa Digital PCR Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Component

10.2.3. By Application

10.2.4. By End User

10.2.5. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Digital PCR Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Component

10.3.1.2.3. By Application

10.3.1.2.4. By End User

10.3.2. Saudi Arabia Digital PCR Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Component

10.3.2.2.3. By Application

10.3.2.2.4. By End User

10.3.3. UAE Digital PCR Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Component

10.3.3.2.3. By Application

10.3.3.2.4. By End User

10.3.4. Egypt Digital PCR Market Outlook

10.3.4.1. Market Size & Forecast

10.3.4.1.1. By Value

10.3.4.2. Market Share & Forecast

10.3.4.2.1. By Type

10.3.4.2.2. By Component

10.3.4.2.3. By Application

10.3.4.2.4. By End User

10.3.5. Turkey Digital PCR Market Outlook

10.3.5.1. Market Size & Forecast

10.3.5.1.1. By Value

10.3.5.2. Market Share & Forecast

10.3.5.2.1. By Type

10.3.5.2.2. By Component

10.3.5.2.3. By Application

10.3.5.2.4. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Competitive Landscape

13.1. Business Overview

13.2. Company Snapshot

13.3. Products & Services

13.4. Financials (As reported)

13.5. Recent Developments

13.6. SWOT Analysis

13.6.1. Bio-Rad Laboratories, Inc.

13.6.2. Fluidigm Corporation

13.6.3. F. Hoffmann-La Roche AG

13.6.4. Merck KGaA

13.6.5. QIAGEN N.V.

13.6.6. Thermo Fisher Scientific Inc.

13.6.7. Genetron Holdings Limited

13.6.8. Naveris, Inc.

13.6.9. SAGA Diagnostics

13.6.10. Precigenome LLC

14. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Digital PCR Market?

Rise in the prevalence of infectious diseases, an increase in awareness and acceptance of personalized medicines, and advancements in the techniques are the major drivers for the global digital PCR market.

Who are the top players operating in the Digital PCR Market?

Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC are the leading players operating in the Global Digital PCR Market.